8,9-脫氫雌酮

8,9-脫氫雌酮
臨床資料
其他名稱	Δ8-Estrone; Estra-1,3,5(10),8-tetraen-3-ol-17-one
給藥途徑	By mouth
藥物類別（英語：Drug class）	Estrogen
識別資訊
	IUPAC命名法 (13S,14S)-3-Hydroxy-13-methyl-7,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one; ;
CAS號	474-87-3
PubChem CID	6451472;
ChemSpider	4953937;
UNII	7C1N8RKG9F;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID40197125 ;
化學資訊
化學式	C18H20O2
摩爾質量	268.36 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES C[C@]12CCC3=C([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O;
	InChI InChI=1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,16,19H,2,4,6-9H2,1H3/t16-,18-/m0/s1; Key:OUGSRCWSHMWPQE-WMZOPIPTSA-N;

8,9-脫氫雌酮（英語：8,9-Dehydroestrone，Δ⁸-estrone）也稱為異馬烯雌酮（英語：isoequilin）是一種存在於馬中的天然雌激素，半系統名：雌甾-1,3,5(10),8-四烯-3-醇-17-酮，estra-1,3,5(10),8-tetraen-3-ol-17-one^[1]。8,9-脫氫雌酮的3-硫酸酯是結合型雌激素（普立馬）的成分之一，約占3.5%^[2]。8,9-脫氫雌酮在體內可轉化成8,9-脫氫雌二醇，過程類似於雌酮轉化成雌二醇^[3]^[4]。

參考文獻

^ Baracat E, Haidar M, Lopez FJ, Pickar J, Dey M, Negro-Vilar A. Estrogen activity and novel tissue selectivity of delta8,9-dehydroestrone sulfate in postmenopausal women. J. Clin. Endocrinol. Metab. June 1999, 84 (6): 2020–7. PMID 10372704. doi:10.1210/jcem.84.6.5800  .
^ Marc A. Fritz; Leon Speroff. Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins. 28 March 2012: 751– [2022-02-06]. ISBN 978-1-4511-4847-3. （原始內容存檔於2021-05-03）.
^ Bhavnani BR. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc. Soc. Exp. Biol. Med. January 1998, 217 (1): 6–16. PMID 9421201. S2CID 45177839. doi:10.3181/00379727-217-44199.
^ Bhavnani BR, Cecutti A, Gerulath A. Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men. J. Steroid Biochem. Mol. Biol. October 1998, 67 (2): 119–31. PMID 9877212. S2CID 54352249. doi:10.1016/s0960-0760(98)00082-x.

[pmid10372704-1] Baracat E, Haidar M, Lopez FJ, Pickar J, Dey M, Negro-Vilar A. Estrogen activity and novel tissue selectivity of delta8,9-dehydroestrone sulfate in postmenopausal women. J. Clin. Endocrinol. Metab. June 1999, 84 (6): 2020–7. PMID 10372704. doi:10.1210/jcem.84.6.5800  .

[FritzSperoff2012-2] Marc A. Fritz; Leon Speroff. Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins. 28 March 2012: 751– [2022-02-06]. ISBN 978-1-4511-4847-3. （原始內容存檔於2021-05-03）.

[pmid9421201-3] Bhavnani BR. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc. Soc. Exp. Biol. Med. January 1998, 217 (1): 6–16. PMID 9421201. S2CID 45177839. doi:10.3181/00379727-217-44199.

[pmid9877212-4] Bhavnani BR, Cecutti A, Gerulath A. Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men. J. Steroid Biochem. Mol. Biol. October 1998, 67 (2): 119–31. PMID 9877212. S2CID 54352249. doi:10.1016/s0960-0760(98)00082-x.

[1]

[2]

[3]

[4]

臨床資料

其他名稱	Δ⁸-Estrone; Estra-1,3,5(10),8-tetraen-3-ol-17-one
給藥途徑	By mouth
藥物類別（英語：Drug class）	Estrogen
識別資訊
IUPAC命名法 (13S,14S)-3-Hydroxy-13-methyl-7,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one
CAS號	474-87-3
PubChem CID	6451472
ChemSpider	4953937
UNII	7C1N8RKG9F
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID40197125
化學資訊
化學式	C₁₈H₂₀O₂
摩爾質量	268.36 g·mol⁻¹
3D模型（JSmol（英語：JSmol））	交互式圖像
SMILES C[C@]12CCC3=C([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O
InChI InChI=1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,16,19H,2,4,6-9H2,1H3/t16-,18-/m0/s1 Key:OUGSRCWSHMWPQE-WMZOPIPTSA-N